Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis
At visit 3 (V3), HbA1c levels were documented in the electronic case report form
This probe is primarily used to visualize production
"Retatrutide phase 2 obesity trial outcomes and metabolic effects." Clinical Trial Registry Database
The reasons for these failures often include short in vivo half-life, chemical instability, limited cellular uptake, poor bioavailability, lack of targeted delivery to specific tissues or (sub)cellular compartments, a narrow therapeutic index, and toxicity
This shift elevates the oxygen demand and leads to mitochondrial dysfunction, resulting in cardiomyocyte death and ventricular dysfunction